adenosine deaminase, RNA-specific
| GO Term | Evidence Code | PMID |
|---|---|---|
| osteoblast differentiation |
|
|
| in utero embryonic development |
|
|
| hematopoietic progenitor cell differentiation |
|
|
| somatic diversification of immune receptors via somatic mutation |
|
|
| adenosine to inosine editing |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| nucleus |
|
|
| nucleus |
|
|
| nucleus |
|
|
| nucleoplasm |
|
|
| nucleoplasm |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| DNA binding |
|
|
| left-handed Z-DNA binding |
|
|
| RNA binding |
|
|
| double-stranded RNA binding |
|
|
| double-stranded RNA adenosine deaminase activity |
|
| Gene Ontology |
|---|
| adenosine deaminase activity |
| adenosine to inosine editing |
| double-stranded RNA binding |
| tRNA-specific adenosine deaminase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050629 | Aicardi-Goutieres syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026